SCHEMBL14140481

SCHEMBL14140481

CCC(=O)CCNc1nccc(-c2ccnc(Nc3cccc(Cl)c3)n2)c1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAMK2D Q13557 3/20 0.49
PIK3CA P42336 2/20 0.48
PIK3CB P42338 2/20 0.48
PIK3CG P48736 2/20 0.48
ABL1 P00519 2/20 0.48
BCR P11274 2/20 0.48
PRKCA P17252 1/20 0.48
PRKCD Q05655 1/20 0.48
CDK2 P24941 4/20 0.47
MAPT P10636 3/20 0.47
CDK4 P11802 2/20 0.47
NPC1 O15118 2/20 0.47
XBP1 P17861 2/20 0.47
MAPK1 P28482 2/20 0.47
HTT P42858 2/20 0.47
RAB9A P51151 2/20 0.47
CDK5 Q00535 2/20 0.47
CDK5R1 Q15078 2/20 0.47
CCNT1 O60563 1/20 0.47
CDK1 P06493 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3608406 0.91 CAMK2D (0.53) CAMK2DPIK3CAPIK3CBPIK3CGABL1
SCHEMBL3609046 0.85 CDK1 (0.65) CAMK2DPIK3CAPIK3CBPIK3CGABL1
SCHEMBL3609491 0.85 CAMK2D (0.53) CAMK2DPIK3CAPIK3CBPIK3CGABL1
SCHEMBL3605169 0.85 CDK2 (0.51) CAMK2DPIK3CAPIK3CBPIK3CGABL1
SCHEMBL3596068 0.83 CDK2 (0.49) CAMK2DPIK3CAPIK3CBPIK3CGABL1
SCHEMBL3602192 0.83 CAMK2D (0.58) CAMK2DPIK3CAPIK3CBPIK3CGABL1
SCHEMBL3597064 0.81 PIK3CA (0.52) CAMK2DPIK3CAPIK3CBPIK3CGABL1
SCHEMBL3603147 0.81 CAMK2D (0.52) CAMK2DPIK3CAPIK3CBPIK3CGABL1
SCHEMBL3613301 0.81 CAMK2D (0.49) CAMK2DPIK3CAPIK3CBPIK3CGABL1
SCHEMBL3617505 0.80 MAPT (0.53) CAMK2DPIK3CAPIK3CBPIK3CGABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008079933-A2 HETEROARYL-HETEROARYL COMPOUNDS AS CDK INHIBITORS FOR THE TREATMENT OF CANCER, INFLAMMATION AND VIRAL INFECTIONS NOVARTIS AG (CH) 2008-07-03 WO disclosed